Consolidated Operations Group (COG)

Size: px
Start display at page:

Download "Consolidated Operations Group (COG)"

Transcription

1 Consolidated Operations Group (COG) 10 April 2018 Outperform Upgrade to OUTPERFORM - Inflection point nearing $0.10 Jason Palmer jpalmer@taylorcollison.com.au Summary (AUD) Market Capitalisation $130.8 Share Price $ week low $ week high $0.158 Ave Monthly Vol (year rolling) M Key Financials (AUD) Year End ($m) 1H18 Act. FY18 Est. FY19 Est. Revenue EBIT NPAT EPS (c) Growth (pcp) 67.7% 43.2% 19.7% PE Ratio (x) n/a DPS (c) Div Yield n/a 3.5% 6.0% Franking 0% 100.0% 100.0% EV n/a EV/EBITDA (x) n/a EV/EBIT (x) n/a ROE n/a 3.2% 4.2% EBIT Margin 10.2% 12.1% 12.9% Payout Ratio. n/a 43.1% 61.7% Share Price Graph (AUD) Earnings Update The 1H18 result continued to highlight positive trends within the Group, namely: (1) 7% growth in NAF on pcp; (2) Additions in platform partner brokers which should underpin earnings momentum into 2H18 and FY19; (3) Increases in some volume base incentives; (4) Firming acquisition pipeline; and (5) Ongoing lease book expansion supported by a sixth funder signing on. Despite this, a slower than expected broker roll-up to date, combined with building corporate disclosures has resulted in considerable share price softness in the past 12-months. Nevertheless, we believe the inflection point for earnings acceleration from acquisitive and organic growth is nearing. To this end, we expect the medium term outlook to be far brighter than recent times. Investment Thesis Operating in an aging and highly fragmented industry with $40m of surplus cash, COG looks unchallenged in the roll-up of the asset finance broker market in Australia. A proven money maker at the helm highly aligned with shareholders is appealing as is the Company s shrewd approach to acquisitions over the past two years. Invoking a buyback for the next 12- months was a surprise given the strength of the acquisition pipeline, however, we expect the take up to be negligible. The growing lease book should lead to significant yearly accounting profit expansion through FY20-FY22. In saying this, cash profit will be significantly backend weighted, and therefore an element of trust me is needed as end of lease returns are evenly recognised throughout the term of the lease. We take comfort that the Group has a long history of average end of lease returns of 22% and that origination growth has been relatively steady since We also like that a sixth funder has been added to the existing panel at better terms of trade bolstering funding options. Valuation & Recommendation In our view the complexity in valuing a growing lease book while working through the changes in reporting and accounting as a LIC to now a trading company is reflected in the Group's current valuation. We also emphasise management disclosures are on the improvement. This trend is expected to continue into the FY18 Result. We believe a sum-of-parts valuation best suits COG, comprising a DCF on the lease book and a 12x NPATA multiple on the rest of the business (broking, ancillary and head office), a 20% premium to listed mortgage finance brokers. While funding limits allow for ongoing lease book growth in the short-term, these can be removed at any time without notice. History shows this should not be taken as perpetual in nature. To this end, while new business origination of the lease book could exceed $60m p.a. into the foreseeable future, we have allowed for up to a 33% portfolio decline in our calculation of the NPV. In our view this provides adequate downside protection in our valuation methodology. Average monthly traded volumes are ~1.5% of the register. Therefore, we believe a liquidity discount of 15% should be applied to our estimated fair value of 14.2cps. Trading at a 20% discount to our liquidity adjusted fair value of 12.1cps we upgrade our recommendation from HOLD to OUTPERFORM.

2 Consolidated Operations Group Page 2 of 5 Cons Operations Gp - Summary of Forecasts Price $ PROFIT & LOSS SUMMARY (A$m) BALANCE SHEET SUMMARY Year Ended FY17PF 1H18A FY18E FY19E Year Ended FY17A 1H18A FY18E FY19E Operating Revenue Cash Total Revenue Receivables EBITDA Adj Lease Receivables Dep'n (2.1) (0.6) (1.3) (0.7) Inventories Amort'n (0.4) (2.3) (4.5) (4.6) Other EBIT Adj Total Current Assets Net Interest (1.9) (1.3) (3.4) (5.1) Receivables Pre- Tax Profit Adj Lease Receivables Tax Expense (5.4) (1.7) (4.1) (4.9) Property Plant & Equip Minorities (4.1) (1.8) (4.6) (5.3) Intangibles NPAT Adj Equity Accounted Associates Abnormals (net of tax) (0.6) (0.2) (0.2) 0.0 Other Reported Profit Total Non- Current Assets TOTAL ASSETS Margins on Sales Revenue Accounts Payable EBITDA Adj. 15.4% 14.1% 16.1% 16.0% Borrowings EBIT Adj. 13.3% 10.2% 12.1% 12.9% Provisions NPAT Adj. 4.1% 3.8% 4.2% 4.6% Other Total Current Liab Change on pcp Borrowings Total Revenue n/a 35.5% 22.6% 21.3% Provisions EBITDA Adj. n/a 38.3% 28.4% 20.2% Other EBIT Adj. n/a 16.7% 11.6% 29.9% Total Non- Current Liab NPAT Adj. n/a 37.3% 25.4% 32.9% TOTAL LIABILITIES TOTAL EQUITY S EGMENTS Year Ended FY17PF 1H18A FY18E FY19E CASH FLOW SUMMARY Revenue Year Ended FY17A 1H18A FY18E FY19E Finance Broking & Aggregation EBIT (excl Abs/Extr) Commercial Equipment Leasing Add: Depreciation & Amortisation All Other Change in Working Capital (1.0) Other non cash/unusual items (0.2) 2.2 (0.2) 0.0 Less: Tax Paid (3.7) (1.7) (4.1) (4.9) EBITDA Net Interest 0.4 (1.3) (3.4) (5.1) Finance Broking & Aggregation Gross Cashflows Commercial Equipment Leasing Net Capex (0.6) (0.1) (0.7) (0.7) All Other (3.8) (1.3) (2.4) (2.1) (Acquisitions) / Divestments (25.2) (1.5) (17.5) (19.8) Net Finance Lease/Advances (20.8) (26.3) (40.9) (15.2) Free Cashflows (39.9) (14.1) (39.6) (18.6) PER SHARE DATA Dividends Paid (1.8) (1.9) (4.6) (7.8) Year Ended FY17PF 1H18A FY18E FY19E Debt issued / (Repaid) EPS Adj (c ) Equity issued / ( Buyback) Growth (pcp) n/a 67.7% 43.2% 19.7% Net Cash Flow (13.2 ) (9.3 ) Ordinary Dividend (c) Special Dividend (c) VALUATION MULTIPLES Franking n/a 100% 100% 100% Year Ended FY17A 1H18A FY18E FY19E Gross CF per Share (c) PER (x) 21.7 n/a NTA per share (c) PER Adj. (x) n/a n/a Dividend Yield (%) 0.0 % n/a 3.5 % 6.0 % KEY RATIOS Free CF Yield % n/a % % Year Ended FY17PF 1H18A FY18E FY19E EV/EBITDA Adj. (x) 6.6 n/a Net Debt / EBITDA Adj. (x) (0.6) n/a EV/EBIT (Adj.) (x) 7.6 n/a Net Debt : Equity (%) - 5.8% 2.1% 17.4% 31.1% EBIT Interest cover (x) n/a n/a Free CF / NPAT Adj. (3 yr avg) n/a n/a n/a -297% Current ratio (x) ROE Adj. (%) n/a n/a 3.2% 4.2% Dividend Payout Ratio Adj. (%) 0.0% 0.0% 43.1% 61.7% Assumptions: Nil buyback exercised. Assumes $16m cash deployed towards broker acquisitions in late FY18 and $19.8m during mid FY19. TC has not restated FY17PF for changes in acquisition accounting.

3 Consolidated Operations Group Page 3 of 5 Peer Comparison and Valuation Thoughts (same methodology The lease book adds complexity to the valuation The fragility of the TL Rental s business became evident during the GFC and the years that followed. Access to capital tightened inhibiting its ability to replenish the book. Off-balance sheet exposures combined with the deferred nature of cash flow earnings adds valuation complexities. We believe the best way to value the lease book is on a DCF basis. A prudent measure in our DCF valuation includes discounting new business origination from current levels of $55m p.a. to $40m p.a. to account for future possible funding constraints. Using this approach we arrive at a fair value on the lease book of $63m as a going concern business or $19.6m if you were valuing the business in run-off. Our DCF assumptions are detailed below. Year of Origination FY14 FY15 FY16 FY17 FY18-20 Lease book origination Interest Spread 4% 4% 4% 4% 4% Lease term (4 years) Write off rate -2% -2% -2% -2% -2% End of lease earnings 22% 22% 22% 22% 22% Perpetual Growth rate 2.0% 2.0% 2.0% 2.0% 2.0% Discount Rate New Lease Origination into Perpetuity $20m $30m $40m $50m $60m Run-off 10% % % % COG s business is not of the same quality as SDF or AUB and therefore should trade at a discount to both COG should trade at a discount to SDF and AUB because: 1. Unlike insurance which is largely recession proof, assets finance generation is driven by business trading conditions; and 2. At present independent members only remain part of the Group because VBIs are higher. There is no guarantee this will continue. LISTED AUS INSURANCE BROKERS Mkt Cap PE EV/EBITDA EV/EBIT (AU$m) Yr 1 Yr 2 Yr 1 Yr 2 Yr 1 Yr 2 AUB Group Steadfast Group 1,

4 Consolidated Operations Group Page 4 of 5 Instead, we believe Australian listed mortgage finance aggregators are a better valuation yard-stick for COG s broking operations because origination is transaction dependent. In our view COG s broking business is more closely aligned to MOC rather than AFG because it does not take on the financing risk. In saying this, macro conditions remain more appealing for COG into the medium term than it does for the listed mortgage finance brokers, and therefore, we believe COG should trade at a 20% premium or 12x EPS. LISTED AUS MORTGAGE BROKERS Mkt Cap PE EV/EBITDA EV/EBIT (AU$m) Yr 1 Yr 2 Yr 1 Yr 2 Yr 1 Yr 2 Mortgage Choice Australian Finance Group As shown in the table below, we have added back amortisation from acquisition accounting plus taken up the full year benefit of acquisitions in the next 12-months to arrive at a run-rate adjusted NPATA. NPATA Attributable to COG Members Reporting Segment FY19 Finance Broking & Aggregation 7.4 Annualised benefit of FY19 Acquisitions (net of tax) 1.3 Amortisation on acquisitions (net of tax and minorities) 1.8 All Other / Intersegment (1.1) TOTAL 9.3 The sensitivity table below shows the fair valuation impact to the broking business per 1 P/E point. Fair Value on price to earnings basis (Finance Broking & Aggregation + all other) 8x 9x 10x 11x 12x 13x 14x FY FY Our sum-of-parts valuation supports 20% uplift in the share price in the next 12-months Our sum-of-parts valuation arrives at a fair value of 12.1cps based on our FY19e (inclusive of a 15% liquidity discount), a 20% discount to the current share price. Therefore, we upgrade our recommendation from HOLD to OUTPERFORM. Sum-of-parts Valuation FY19 FY19 FY19 FY19 Liquidity Discount 0% 5% 10% 15% Finance Broking + all other Lease Book Excess Cash (net of Working Capital $5m) TOTAL Shares on issue 1, , , ,307.5 FV per share Current share price Discount/(Premium) FV 42.0% 34.9% 27.8% 20.7%

5 Consolidated Operations Group Page 5 of 5 The following Warning, Disclaimer and Disclosure relate to all material presented in this document and should be read before making any investment decision. Disclaimer: Warning (General Advice Only): Past performance is not a reliable indicator of future performance. This report is a private communication to clients and intending clients and is not intended for public circulation or publication or for the use of any third party, without the approval of Taylor Collison Limited ABN ("Taylor Collison"), an Australian Financial Services Licensee and Participant of the ASX Group. TC Corporate Pty Ltd ABN ( TC Corporate ) is a wholly owned subsidiary of Taylor Collison Limited. While the report is based on information from sources that Taylor Collison considers reliable, its accuracy and completeness cannot be guaranteed. This report does not take into account specific investment needs or other considerations, which may be pertinent to individual investors, and for this reason clients should contact Taylor Collison to discuss their individual needs before acting on this report. Those acting upon such information and recommendations without contacting one of our advisors do so entirely at their own risk. This report may contain forward-looking statements". The words "expect", "should", "could", "may", "predict", "plan" and other similar expressions are intended to identify forward-looking statements. Indications of and guidance on, future earnings and financial position and performance are also forward looking statements. Forward-looking statements, opinions and estimates provided in this report are based on assumptions and contingencies which are subject to change without notice, as are statements about market and industry trends, which are based on interpretations of current market conditions. Any opinions, conclusions, forecasts or recommendations are reasonably held at the time of compilation but are subject to change without notice and Taylor Collison assumes no obligation to update this document after it has been issued. Except for any liability which by law cannot be excluded, Taylor Collison, its directors, employees and agents disclaim all liability (whether in negligence or otherwise) for any error, inaccuracy in, or omission from the information contained in this document or any loss or damage suffered by the recipient or any other person directly or indirectly through relying upon the information. Disclosure: This report was prepared solely by Taylor Collison Limited. ASX did not prepare any part of the report and has not contributed in any way to its content. The role of ASX in relation to the preparation of the research reports is limited to funding their preparation, by Taylor Collison Limited, in accordance with the ASX Equity Research Scheme. ASX does not provide financial product advice. The views expressed in this research report may not necessarily reflect the views of ASX. To the maximum extent permitted by law, no representation, warranty or undertaking, express or implied, is made and no responsibility or liability is accepted by ASX as to the adequacy, accuracy, completeness or reasonableness of the research reports. The Analysts remuneration is not linked to the rating outcome in this research document. Taylor Collison may solicit business from any company mentioned in this report. For the securities discussed in this report, Taylor Collison may make a market and may sell or buy on a principal basis. Taylor Collison, or any individuals preparing this report, may at any time have a position in any securities or options of any of the issuers in this report and holdings may change during the life of this document. Taylor Collison has been appointed on-market broker for the share buyback for the period 2 April 2018 to 1 April Analyst Interests: The Analyst may hold the product referred to in this document, but Taylor Collison Limited considers such holdings not to be sufficiently material to compromise the rating or advice. Analyst holdings may change during the life of this document. Analyst Certification: The Analyst certifies that the views expressed in this document accurately reflect their personal, professional opinion about the financial products to which this document refers. Date Prepared: April 2018 Author: Jason Palmer Release Authorised by: Mark Pittman

AtCor Medical Holdings Limited (ACG)

AtCor Medical Holdings Limited (ACG) Volume (million) AtCor Medical Holdings Limited (ACG) 30 March 2015 Speculative Buy Value Creation Ahead Post CPT1 Code Award $0.20 Marcus Hamilton mhamilton@taylorcollison.com.au +61 2 9210 1317 Summary

More information

MNF Group Limited (MNF)

MNF Group Limited (MNF) MNF Group Limited (MNF) 16 February 2018 Outperform 1H18 Results: Excessive Sell-off Presents Buying Opportunity $5.14 Chris Reindler creindler@taylorcollison.com.au +61 2 9210 1335 Summary (AUD) Market

More information

Appen Limited (APX-AU) 29 August 2017

Appen Limited (APX-AU) 29 August 2017 Appen Limited (APX-AU) 29 August 2017 Pricing in another Upgrade Marketperform Adam Dellaverde adamd@taylorcollison.com.au +618 8217 3923 +6403 013 032 Summary Market capitalisation ($m) $438.7 Share price

More information

CogState Limited (CGS)

CogState Limited (CGS) CogState Limited (CGS) 26 August 2010 Outperform FY10 NPAT of $1.6m; Launches Axon Sports JV $0.24 Thomas Duthy PhD MBA tduthy@taylorcollison.com.au +61 2 9377 1500 Summary Market Capitalisation (M) $15.8

More information

PMP Limited (PMP-AU) 5 September 2017 Synergies on Target, Cash Flow set to Ramp

PMP Limited (PMP-AU) 5 September 2017 Synergies on Target, Cash Flow set to Ramp PMP Limited (PMP-AU) 5 September 2017 Synergies on Target, Cash Flow set to Ramp Adam Dellaverde adellaverde@taylorcollison.com.au +618 8217 3923 Summary Market capitalisation ($m) $359.3 Share price $0.71

More information

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS

BUY SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS BUY 0.11 0.39 0.69 SHARE PRICE CASH EARNINGS ($M) COMPANY DATA & RATIOS CONTENTS Competitors Products Sales channels Pricing Model INVESTMENT THESIS COMPANY OVERVIEW INDUSTRY OVERVIEW COMPETITORS BOARD

More information

Wisr Ltd (DirectMoney)

Wisr Ltd (DirectMoney) Wisr Ltd (DirectMoney) Interim result draws a line in the sand Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace-lending sector. The company has

More information

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates

Insurance Brokers SECTOR REPORT. Solid Hold. -4% Jun-12. Dec-12. Mar-13. Sep-13. Sep-12. Jun-13. Source: APRA, Baillieu Holst estimates 11 May 2018 RECOMMENDATIONS AUB Group (AUB) Rating HOLD Risk Low Price Target $14.50 Share Price $14.17 Steadfast Group (SDF) Rating HOLD Risk Low Price Target $2.80 Share Price $2.88 RESEARCH ANALYST

More information

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views

Fund Managers. Aust. Fund managers review & rank AUSTRALIA. Event. Stock Views AUSTRALIA 4 February 2016 Macquarie Securities (Australia) Limited Aust. Fund managers review & rank Event We review and rank the listed Australian under Macquarie Securities coverage, assessing fund performance,

More information

Platinum Asset Management

Platinum Asset Management AUSTRALIA PTM AU Price (at 06:10, 11 Jul 2016 GMT) Neutral A$5.52 Valuation A$ - DCF (WACC 9.3%, beta 1.2, ERP 5.0%, RFR 3.3%) 5.19 12-month target A$ 5.36 12-month TSR % +2.6 Volatility Index Low/Medium

More information

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016.

IOOF. Positive flows in 1Q17. FUM and Net Flows for September Qtr Source: Company data, Macquarie Research, Oct 2016. AUSTRALIA IFL AU Price (at 06:35, 26 Oct 2016 GMT) Outperform A$8.34 Valuation A$ - DCF (WACC 8.8%, beta 1.1, ERP 5.0%, RFR 3.3%) 8.74 12-month target A$ 9.00 12-month TSR % +14.3 Volatility Index Low/Medium

More information

Asset revaluation driven by almonds

Asset revaluation driven by almonds Company update 20 July 2015 RURAL FUNDS GROUP (RFF) Asset revaluation driven by almonds We retain a BUY rating with a 12-month target of $1.15 p/unit. RFF is a listed property trust with a portfolio of

More information

Praemium (PPS) COMPANY REPORT. Model performance

Praemium (PPS) COMPANY REPORT. Model performance 14 August 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.41 SNAPSHOT Monthly Turnover $9.5mn Market Cap $165mn Shares Issued 398.5mn 52-Week High $0.54 52-Week

More information

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation

Boart Longyear. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA BLY AU Price (at 08:01, 12 Sep 2013 GMT) Neutral A$0.50 Valuation A$ 0.71 - DCF (WACC 10.1%, beta 1.5, ERP 0.1%, RFR 0.1%, TGR 0.0%) 12-month target A$ 0.56 12-month TSR % +12.0 Volatility Index

More information

MEDICAL DEVELOPMENTS INTERNATIONAL LTD

MEDICAL DEVELOPMENTS INTERNATIONAL LTD MEDICAL DEVELOPMENTS INTERNATIONAL LTD No pain in Germany HOLD Pharmaceuticals, Biotechnology & Life Sciences / Pharmaceuticals 6 April 2018 COMPANY UPDATE Ticker MVP Stock Price $7.10 Target Price $8.08

More information

Regional Express Holdings Ltd REX

Regional Express Holdings Ltd REX 20 February 2006 REX $1.15 Analyst Ken Fleming (613) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (613) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$132.3M Performance & Valuation Last

More information

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cardno. Tough half over A$2.88 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA CDD AU Price (at 04:53, 17 Feb 2015 GMT) Neutral A$2.88 Valuation - Sum of Parts A$ 2.80-3.43 12-month target A$ 3.12 12-month TSR % +18.4 Volatility Index Medium GICS sector Capital Goods Market

More information

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation

Challenger. Normalised margin trends expected to decline. Earnings and target price revision. Price catalyst. Action and recommendation 1H13E 2H13E 1H14E 2H14E 1H15E 2H15E AUSTRALIA CGF AU Price (at CLOSE#, 20 Aug 2012) Outperform A$3.76 Volatility index Low 12-month target A$ 4.57 12-month TSR % +26.4 Valuation - Sum of Parts A$ 4.57

More information

Wisr Ltd (DirectMoney)

Wisr Ltd (DirectMoney) Wisr Ltd (DirectMoney) Strategic placement at 56% premium to previous close Wisr Limited (WZR.AX) is an online consumer lending platform competing in the rapidly growing marketplace lending sector. The

More information

Praemium (PPS) COMPANY REPORT. Quartermaster

Praemium (PPS) COMPANY REPORT. Quartermaster 10 October 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.58 Share Price $0.45 SNAPSHOT Monthly Turnover $9.2mn Market Cap $162mn Shares Issued 399.6mn 52-Week High $0.54 52-Week

More information

Generation Healthcare REIT

Generation Healthcare REIT AUSTRALIA GHC AU Price (at 06:13, 24 Aug 2015 GMT) Neutral A$1.65 Valuation - Sum of Parts A$ 1.51-1.59 12-month target A$ 1.59 12-month TSR % +1.8 Volatility Index Low GICS sector Real Estate Market cap

More information

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins.

SG Fleet Group % growth in FY17. Earnings and target price revision. Price catalyst. Catalyst: Results and contract wins. AUSTRALIA SGF AU Price (at 07:57, 27 Oct 2016 GMT) Outperform A$3.85 Valuation - PER A$ 3.92-4.18 12-month target A$ 4.37 12-month TSR % +18.1 Volatility Index Medium GICS sector Commercial & Professional

More information

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW

WINDLAB LTD HOLD. Lakeland financial close delayed again. Downgrade to HOLD. COMPANY UPDATE EVENT IMPACT INVESTMENT VIEW WINDLAB LTD HOLD Lakeland financial close delayed again. Downgrade to HOLD. Utilities / Renewable Electricity 7 November 2018 COMPANY UPDATE Ticker WND Stock Price $1.180 Target Price $1.350 Forecast Capital

More information

Resetting expectations

Resetting expectations Company update 13 May 2016 TPI ENTERPRISES (TPE) Resetting expectations We retain a BUY rating with a revised 12-month price target of $3.21 p/sh. We assess market conditions to imply a more gradual ramp

More information

Vista Group International

Vista Group International NEW ZEALAND VGL NZ Price (at 03:15, 26 Feb 2015 GMT) Outperform NZ$4.35 Valuation NZ$ 4.31 - DCF (WACC 9.9%, beta 1.0, ERP 7.0%, RFR 4.0%, TGR 2.0%) 12-month target NZ$ 4.75 12-month TSR % +9.5 Volatility

More information

PRICE $1.30 Regional Express Holdings Ltd REX

PRICE $1.30 Regional Express Holdings Ltd REX 16 November 2006 PRICE $1.30 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115M Market cap A$133M

More information

Zespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research

Zespri. Vote for change and SunGold licence sales underpin a strong outlook COMPANY RESEARCH. Private Wealth Research COMPANY RESEARCH 8 MAY 218 Private Wealth Research Zespri Vote for change and SunGold licence sales underpin a strong outlook Key data Code Current price ZGL NZ$8.7 Over the past 6 months since our initiation

More information

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation

Family Zone Cyber Safety Limited (FZO) Company Update. Investment Summary. Investment Highlights. Investment Recommendation BW EQUITIES RESEARCH 14 March 2017 Family Zone Cyber Safety Limited (FZO) Company Update BUY Rating: Target Price 1 : $0.46 Projected Return: 109% 1 12 month target Company Statistics Share Price (A$)

More information

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts

Noni B (NBL) BUY: FY18e EBITDA +12.8% Key points. Risks and catalysts Date 09 January 2018 Theme Company Update Company Noni B (NBL) BUY: FY18e EBITDA +12.8% NBL provided a positive 1H18 trading update today, advising LFL sales growth of 3.0% (1.5% in 1H17) and EBITDA of

More information

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation

Earnings and target price revision. Price catalyst. Catalyst: 1H14 result in February Action and recommendation AUSTRALIA CBA AU Price (at 06:10, 10 Sep 2013 GMT) Neutral A$73.63 Valuation A$ - DCF (WACC 10.3%, beta 1.0, ERP 5.0%, RFR 5.5%) 50.40 12-month target A$ 66.15 12-month TSR % -5.0 Volatility Index Low

More information

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2

Genex Power (GNX) COMPANY REPORT. NAIF lined up for Stage 2 21 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Speculative Price Target $0.37 Share Price $0.31 SNAPSHOT Monthly Turnover $2.5mn Market Cap $91mn Shares Issued 303.9mn 52-Week High $0.43 52-Week

More information

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW

COMPUMEDICS LTD HOLD. CMP Downgrades FY17 Guidance COMPANY UPDATE EVENT KEY TAKE-AWAYS INVESTMENT VIEW COMPUMEDICS LTD HOLD CMP Downgrades FY17 Guidance Health Care Equipment & Services / Health Care Equipment 7 July 2017 COMPANY UPDATE Ticker CMP Stock Price $0.560 Target Price $0.530 Forecast Capital

More information

Freedom Insurance (FIG)

Freedom Insurance (FIG) 03 November 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk Medium Price Target $0.85 Share Price $0.50 SNAPSHOT Monthly Turnover $13.0mn Market Cap $169mn Shares Issued 239.7mn 52-Week High $0.97 52-Week

More information

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision.

Eclipx Group. Highlights its funding flexibility A$3.77 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA ECX AU Price (at 02:49, 15 Dec 2016 GMT) Outperform A$3.77 Valuation - PER A$ 3.53-3.78 12-month target A$ 4.22 12-month TSR % +16.3 Volatility Index Low/Medium GICS sector Diversified Financials

More information

Cash Converters Intl.

Cash Converters Intl. MICROCAP COMPANY RESEARCH Cash Converters Intl. 22 nd November 2012 GICS: Diversified Financials Consumer Finance 1Q13 Trading Update RECENT NEW S Cash Converters [ASX:CCV] recently provided a trading

More information

UBS Investment Research Brambles Limited

UBS Investment Research Brambles Limited UBS Investment Research Brambles Limited FY12 result: strong revenue momentum Result highlights strong revenue momentum Brambles FY12 result was slightly ahead of expectations, revealing 11% underlying

More information

SG Fleet Group. Another UK acquisition. Earnings and target price revision

SG Fleet Group. Another UK acquisition. Earnings and target price revision AUSTRALIA SGF AU Price (at 08:26, 30 Nov 2016 GMT) Outperform A$3.23 Valuation - PER A$ 3.96-4.22 12-month target A$ 4.37 12-month TSR % +41.0 Volatility Index High GICS sector Commercial & Professional

More information

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision.

Telstra Corporation. Vodafone better, but far from good A$6.43 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA TLS AU Price (at 11:23, 21 Jul 2015 GMT) Neutral A$6.43 Valuation A$ 6.37 - DCF (WACC 6.8%, beta 0.8, ERP 5.0%, RFR 3.8%, TGR 1.2%) 12-month target A$ 6.30 12-month TSR % +3.3 Volatility Index

More information

Earnings and target price revision. Price catalyst. Action and recommendation

Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA TLS AU Price (at 13:07, 19 Apr 2012 GMT) Outperform A$3.39 Volatility index Low 12-month target A$ 3.55 12-month TSR % +13.0 Valuation A$ - DCF (WACC 9.6%, beta 0.9, ERP 6.0%, TGR 1.0%) 3.55

More information

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare NEW ZEALAND FPH NZ Price (at 05:00, 10 Jul 2015 GMT) Outperform NZ$7.03 Valuation NZ$ 7.39 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.80 12-month TSR % +13.1 Volatility

More information

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation

UGL. Driving growth in DTZ. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA AU Price (at 08:17, 03 Sep 2012 GMT) Underperform A$10.52 Volatility index Low 12-month target A$ 11.08 12-month TSR % +12.0 Valuation A$ - DCF (beta 1.1, ERP 5.0%, RFR 6.0%, TGR 2.5%) 15.09

More information

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts

Noni B (NBL) SFH acquisition could be up to 60% EPS accretive. Key points. Risks and catalysts Date Theme Company Update Company Noni B (NBL) SFH acquisition could be up to 6 EPS accretive Press reports today (Australian) suggest Noni B is a potential acquirer of Specialty Fashion Group (SFH), in

More information

DICKER DATA LIMITED ANNUAL RESULTS

DICKER DATA LIMITED ANNUAL RESULTS DICKER DATA LIMITED ANNUAL RESULTS ANOTHER YEAR OF GROWTH DESPITE SOFT MARKET CONDITIONS Newport Capital produced this report to provide Australian wholesale clients and sophisticated investors with an

More information

Result Focus. Pioneer Credit (PNC) Monday, 27 February 2017

Result Focus. Pioneer Credit (PNC) Monday, 27 February 2017 Result Focus Pioneer Credit (PNC) Monday, 27 February 2017. $2.25 $2.71 $1.94 Share Price $3.02 Positive Neutral Negative Trading Data Last Price $2.07 12 month range $1.60 - $2.09 Market Cap $101m Free

More information

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

NIB Holdings. Lowest in 4 years still enough A$3.72 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA NHF AU Price (at 09:52, 02 Mar 2016 GMT) Outperform A$3.72 Valuation A$ 3.85 - DCF (WACC 8.5%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 2.5%) 12-month target A$ 4.00 12-month TSR % +11.7 Volatility

More information

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation

AMP. Earnings and target price revision. No change. Price catalyst. Action and recommendation AUSTRALIA AU Price (at CLOSE#, 19 Mar 213) Underperform A$5.7 Volatility index Low 12-month target A$ 4.99 12-month TSR % +3.6 Valuation - Sum of Parts A$ 4.68 GICS sector Insurance Market cap A$m 14,855

More information

APN Outdoor Group (APO)

APN Outdoor Group (APO) 26 June 2018 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk Medium Price Target $6.70 Share Price $6.45 SNAPSHOT Monthly Turnover $323.7mn Market Cap $1,069mn Shares Issued 167.0mn 52-Week High $6.70 52-Week

More information

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Silver Chef. Capital raising A$7.71 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SIV AU Price (at 08:50, 21 Mar 2017 GMT) Neutral A$7.71 Valuation - PER A$ 6.68 12-month target A$ 6.68 12-month TSR % -7.4 Volatility Index Medium GICS sector Capital Goods Market cap A$m 278

More information

Wisr Ltd. New products to underpin growth

Wisr Ltd. New products to underpin growth Wisr Ltd Company Update New products to underpin growth Wisr Limited (WZR.AX) is an online consumer lending platform focused on financial wellness and competing in the rapidly growing marketplace lending

More information

Platinum Asset Management (PTM)

Platinum Asset Management (PTM) 24 February 2017 Analyst Lafitani Sotiriou 613 9235 1668 Associate Analyst James Filius 613 9235 1612 Authorisation TS Lim 612 8224 2810 Recommendation Hold (unchanged) Price $5.10 Target (12 months) $4.90

More information

Genworth Mortgage Insurance Australia

Genworth Mortgage Insurance Australia AUSTRALIA GMA AU Price (at 07:29, 05 Aug 2015 GMT) Outperform A$3.50 Valuation A$ - DCF (WACC 12.0%, beta 1.6, ERP 5.0%, RFR 4.5%) 3.52 12-month target A$ 3.47 12-month TSR % +9.2 Volatility Index Medium

More information

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts

MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction. Key points. Risks and catalysts Date Theme Company Update Company MotorCycle Holdings (MTO) New HOLD: Harley still lacking traction We moderate to HOLD (from Buy) with a revised target of $2.36 p/share. We were previously encouraged

More information

Pacific Energy (PEA)

Pacific Energy (PEA) 01 December 2017 INTERNAL ONLY RECOMMENDATIONS Rating BUY Risk High Price Target $0.69 Share Price $0.58 SNAPSHOT Monthly Turnover $5.6mn Market Cap $223mn Shares Issued 371.8mn 52-Week High $0.77 52-Week

More information

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst

Ramsay Health Care. France begins to bite A$66.37 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst AUSTRALIA RHC AU Price (at 06:11, 06 Aug 2015 GMT) Neutral A$66.37 Valuation A$ 64.54 - DCF (WACC 8.1%, beta 1.1, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 70.00 12-month TSR % +7.3 Volatility Index

More information

Apollo Tourism & Leisure Limited (ATL)

Apollo Tourism & Leisure Limited (ATL) Apollo Tourism & Leisure Limited (ATL) 7 November 2017 Hold Initiating Coverage: Fully priced for now $1.735 Jason Palmer jpalmer@taylorcollison.com.au +618 8217 3965 Summary (AUD) Market Capitalisation

More information

Below is the full-list of available criteria in the Lincoln Stock Filter tool:

Below is the full-list of available criteria in the Lincoln Stock Filter tool: Below is the full-list of available criteria in the Lincoln Stock Filter tool: Business description Forecaster count GICS sector (level 1) GICS industry group (level 2) GICS industry (level 3) GICS sub

More information

National Australia Bank

National Australia Bank AUSTRALIA NAB AU Price (at 08:23, 03 Jul 2012 GMT) Outperform A$23.68 Volatility index Low 12-month target A$ 27.66 12-month TSR % +24.9 Valuation A$ - DCF (WACC 12.6%, beta 1.0, ERP 5.0%, RFR 5.8%) 25.14

More information

Vita Group (VTG) COMPANY REPORT. Vitality in question

Vita Group (VTG) COMPANY REPORT. Vitality in question 18 May 2017 INTERNAL ONLY RECOMMENDATIONS Rating HOLD Risk High Price Target $0.85 Share Price $0.90 SNAPSHOT Monthly Turnover $79.4mn Market Cap $137mn Shares Issued 152.6mn 52-Week High $5.47 52-Week

More information

CREDIBLE LABS INC BUY. Partnership Marketing Strategy Paying Off EVENT COMPANY UPDATE HIGHLIGHTS INVESTMENT VIEW. Q4 Activities Report.

CREDIBLE LABS INC BUY. Partnership Marketing Strategy Paying Off EVENT COMPANY UPDATE HIGHLIGHTS INVESTMENT VIEW. Q4 Activities Report. CREDIBLE LABS INC BUY Partnership Marketing Strategy Paying Off Diversified Financials / Other Diversified Financial Services 31 January 2019 COMPANY UPDATE Ticker CRD Stock Price $0.750 Target Price $1.470

More information

AUB GROUP LTD HALF YEAR RESULTS

AUB GROUP LTD HALF YEAR RESULTS AUB GROUP LTD HALF YEAR RESULTS FOR THE PERIOD ENDED 31 DECEMBER 2017 (1H18) 26 FEBRUARY 2018 Page 1 - AUB Group Ltd 1H18 Results NOTICE SUMMARY INFORMATION This document has been prepared by AUB Group

More information

Sims Metal Management

Sims Metal Management AUSTRALIA SGM AU Price (at 5:11, 17 Nov 215 GMT) Outperform A$7.19 Valuation - EV/EBIT A$ 8.49-9.6 12-month target A$ 8.9 12-month TSR % +26.6 Volatility Index Medium GICS sector Materials Market cap A$m

More information

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions

Perpetual (PPT) Oversold, upgrade to Buy. Over 6% yield, with upside in market rally. Quarterly highlights. Earnings revisions 16 April 2018 Analyst Lafitani Sotiriou 613 9235 1668 Authorisation TS Lim 612 8224 2810 Perpetual (PPT) Oversold, upgrade to Buy Recommendation Buy (Hold) Price $42.09 Target (12 months) $47.50 (previously

More information

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Seek. Progresses Zhaopin privatisation A$16.33 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA SEK AU Price (at 06:33, 07 Apr 2017 GMT) Outperform A$16.33 Valuation - Sum of Parts A$ 16.77 12-month target A$ 16.50 12-month TSR % +3.9 Volatility Index Low/Medium GICS sector Commercial &

More information

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team

Crowd Mobile (CM8) A Strong FY17 Result. 24 March Bell Potter Small Cap Team 24 March 2017 Crowd Mobile (CM8) A Strong FY17 Result 1. Crowd Mobile (CM8) delivered a strong set of FY17 results exceeding our revenue expectation by 3.3%, driven by an acceleration in fourth quarter

More information

Stock Focus. Pioneer Credit (PNC) Tuesday, 12 April 2016

Stock Focus. Pioneer Credit (PNC) Tuesday, 12 April 2016 Stock Focus Pioneer Credit (PNC) Tuesday, 12 April 2016. $2.03 $2.48 $1.69 Share Price $2.82 Positive Neutral Negative Trading Data Last Price $1.70 12 month range $1.53 - $1.85 Market Cap $78m Free Float

More information

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision

QBE Insurance. QBE ANZ performance: LMI vs. Excl. LMI (A$m) Source: Company data, Macquarie Research, April 16. Earnings and target price revision AUSTRALIA QBE AU Price (at 10:44, 27 Apr 2016 GMT) Neutral A$11.19 Valuation A$ - DCF (WACC 9.3%, beta 1.1, ERP 5.0%, RFR 3.8%) 11.34 12-month target A$ 12.00 12-month TSR % +12.7 Volatility Index Low/Medium

More information

2014 E 2015 E 2016 E 2017 E

2014 E 2015 E 2016 E 2017 E Equity Research 4 December 2014 Interpump Group Hydraulics M&A may power growth Rating BUY Target price EUR13 Interpump is up 25% since the beginning of the year, bolstered by strong interim results and

More information

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform.

SingTel. Earnings and target price revision. Price catalyst. Action and recommendation. Maintain Outperform. AUSTRALIA SGT AU Price (at 05:10, 06 Dec 2012 GMT) Outperform A$2.59 Volatility index Low 12-month target A$ 2.81 12-month TSR % +14.6 Valuation - Sum of Parts A$ 2.81 GICS sector Telecommunication Services

More information

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook

Australian Banks. Pre-Reporting Form Guide AUSTRALIA. Event. Impact. Outlook AUSTRALIA MRE vs Consensus MQG FY15 Consensus FY15 Date Profit EPS DPS Profit EPS DPS BEN 10-Aug 439 92 67 434 92 67 CBA 12-Aug 9,289 557 420 9,116 554 419 Source: Factset, Macquarie Research, August 2015

More information

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA

Southern Cross Media. Streamlining ahead of reform? A$1.37 AUSTRALIA AUSTRALIA SXL AU Price (at 05:10, 27 Mar 2017 GMT) Neutral A$1.37 Valuation A$ - DCF (WACC 8.0%, beta 1.2, ERP 5.0%, RFR 3.3%) 1.39 12-month target A$ 1.30 12-month TSR % +0.8 Volatility Index Medium GICS

More information

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

3P Learning. Coming to America... A$2.55 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA 3PL AU Price (at 09:19, 02 Mar 2015 GMT) Outperform A$2.55 Valuation - DCF A$ 2.65-3.35 12-month target A$ 3.00 12-month TSR % +18.9 Volatility Index Low/Medium GICS sector Consumer Services

More information

Nanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research

Nanosonics Limited. Australia Health Care Equipment & Supplies. Growth outlook unchanged. Earnings Forecasts. Source Company, LINWAR Research LINWAR Securities 30 August 2011 Nanosonics Limited Australia Health Care Equipment & Supplies Outperform (Unchanged) Price: Target Price: Stock's expected return (12mth) $0.57 $1.20 Capital growth 112.4%

More information

PRICE $1.16 Regional Express Holdings Ltd REX

PRICE $1.16 Regional Express Holdings Ltd REX 13 September 2006 PRICE $1.16 Regional Express Holdings Ltd REX Analyst Ken Fleming (03) 6224 8511 ken.fleming@tricom.com.au Max Wheeler (03) 6224 9899 Fully diluted shares on issue 115.0M Market cap A$121.9M

More information

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Cochlear. Roberts replaced A$88.66 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA COH AU Price (at 06:47, 26 May 2015 GMT) Outperform A$88.66 Valuation A$ 81.19 - DCF (WACC 8.0%, beta 1.0, ERP 5.0%, RFR 3.8%, TGR 3.0%) 12-month target A$ 95.00 12-month TSR % +9.8 Volatility

More information

ONEVIEW HEALTHCARE PLC

ONEVIEW HEALTHCARE PLC ONEVIEW HEALTHCARE PLC BUY 2017 Result Green Shoots Emerging Health Care Equipment & Services / Health Care Technology 28 February 2018 COMPANY UPDATE Ticker ONE Stock Price $1.900 Target Price $3.04 Forecast

More information

Adacel Technologies (ADA)

Adacel Technologies (ADA) 9 November 2018 Chris Savage 612 8224 2835 Authorisation TS Lim 612 8224 2810 Adacel Technologies (ADA) Bad, but not that bad Recommendation Buy (unchanged) Price $0.88 Target (12 months) $1.50 (previously

More information

Kingsgate Consolidated

Kingsgate Consolidated AUSTRALIA KCN AU Price (at 6:11, 31 Jul 215 GMT) Underperform A$.67 Valuation A$ - DCF (WACC 12.%, beta 1.6, ERP 5.%, RFR 3.8%).3 12-month target A$.3 12-month TSR % -54.9 Volatility Index Very High GICS

More information

Petro Rabigh Shutdown marred Q2 results

Petro Rabigh Shutdown marred Q2 results PETROR AB: Saudi Arabia US$5.07bn 17.4% US$11.19mn Market cap Free float Avg. daily volume RSI10 Vol th Target price n/a n/a Consensus price 32.18 48.3% over current Current price 21.70 as at 17/8/2011

More information

Fisher & Paykel Healthcare

Fisher & Paykel Healthcare NEW ZEALAND FPH NZ Price (at 03:59, 16 Mar 2015 GMT) Outperform NZ$6.63 Valuation NZ$ 6.86 - DCF (WACC 8.8%, beta 0.9, ERP 7.0%, RFR 4.5%, TGR 2.0%) 12-month target NZ$ 7.25 12-month TSR % +11.6 Volatility

More information

Spotless Group Holdings

Spotless Group Holdings AUSTRALIA SPO AU Price (at 05:45, 31 Jan 2017 GMT) Neutral A$0.94 Valuation - Peer multiples A$ 1.02 12-month target A$ 1.02 12-month TSR % +18.3 Volatility Index High GICS sector Commercial & Professional

More information

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook

Aged Care. Propco sale & lease back A$2.71 A$5.75 A$6.15 AUSTRALIA. Event. Impact. Outlook AUSTRALIA JHC AU Price (at 06:10, 27 Apr 2015 GMT) Outperform A$2.71 Valuation A$ 2.97 - DCF (WACC 9.1%, beta 1.1, ERP 5.0%, RFR 4.5%, TGR 2.3%) 12-month target A$ 3.00 12-month TSR % +14.7 Volatility

More information

BlueScope Steel. Execution, execution, execution A$12.33 AUSTRALIA. Event. Impact. Earnings and target price revision.

BlueScope Steel. Execution, execution, execution A$12.33 AUSTRALIA. Event. Impact. Earnings and target price revision. AUSTRALIA BSL AU Price (at 05:10, 20 Feb 2017 GMT) Outperform A$12.33 Valuation A$ 13.09 - DCF (WACC 9.0%, beta 1.2, ERP 5.0%, RFR 3.8%, TGR 2.0%) 12-month target A$ 14.30 12-month TSR % +17.0 Volatility

More information

Generation Healthcare REIT All about spread Event

Generation Healthcare REIT All about spread Event AUSTRALIA GHC AU Price (at 04:51, 14 Feb 2015 GMT) Neutral A$1.60 Valuation - Sum of Parts A$ 1.18-1.26 12-month target A$ 1.59 12-month TSR % +5.1 Volatility Index Low GICS sector Real Estate Market cap

More information

INDEPTH RESEARCH NOTE Brambles Ltd Buy

INDEPTH RESEARCH NOTE Brambles Ltd Buy Phone 1300 980 849 Email research@tradingequities.com.au INDEPTH RESEARCH NOTE Brambles Ltd Buy Price: A$9.74 Price Target: A$10.65 ASX: BXB 20 February 2018 Brambles (BXB) 1H18 results were mixed in our

More information

High-Tech. Company Data. Data Source: FactSet

High-Tech. Company Data. Data Source: FactSet APP Securities Company Research 7 June 2018 Silex Systems Ltd SLX-ASX A$0.29 TARGET PRICE A$0.45 HOLD Silex Systems Ltd. is focused on the delivery of the SILEX Laser Enrichment technology for the global

More information

Slater & Gordon Limited

Slater & Gordon Limited BBY Company Research 29 November 2013 Slater & Gordon Limited SGH A$4.39 TARGET PRICE A$5.00 BUY 0.5X Slater & Gordon Limited (SGH) is a national law firm. The Firm's areas of practice include commercial,

More information

Fairfax / REA Group. No housing boom here. A$0.81 Valuation A$ Sum of Parts 12-month target A$ month TSR % +16.0

Fairfax / REA Group. No housing boom here. A$0.81 Valuation A$ Sum of Parts 12-month target A$ month TSR % +16.0 AUSTRALIA FXJ AU Price (at 05:11, 03 Nov 2016 GMT) Outperform A$0.81 Valuation A$ 0.88 - Sum of Parts 12-month target A$ 0.90 12-month TSR % +16.0 Volatility Index Low/Medium Market cap A$m 1,863 30-day

More information

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Meridian Energy. On tax depreciation NZ$2.08 NEW ZEALAND. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation NEW ZEALAND MEL NZ Price (at 05:00, 13 Jul 2015 GMT) Outperform NZ$2.08 Valuation NZ$ 2.50 - DCF (WACC 7.8%, beta 0.6, ERP 7.0%, RFR 3.6%, TGR 2.0%) 12-month target NZ$ 2.60 12-month TSR % +31.7 Volatility

More information

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August

Sirtex Medical. Healthy dose sales. Earnings and target price revision. Price catalyst. Catalyst: FY16 result on the 24th of August AUSTRALIA SRX AU Price (at CLOSE#, 11 Jul 2016) Outperform A$27.88 Valuation A$ 37.93 - DCF (WACC 9.0%, beta 1.2, ERP 5.0%, RFR 3.3%, TGR 1.5%) 12-month target A$ 38.00 12-month TSR % +37.4 Volatility

More information

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24.

ContextVision. Neutral stance maintained after 3Q. 3Q14 Results analysis November 5 th 2014 Share price: NOK Target: NOK 24. 3Q14 Results analysis November 5 th 2014 Share price: NOK 22.00 Target: NOK 24.00 Risk: Medium ContextVision Key share data Sector Reuters Bloomberg ContextVision is a market making client of Norne Securities

More information

INDEPTH RESEARCH NOTE REA Group Ltd Neutral

INDEPTH RESEARCH NOTE REA Group Ltd Neutral 1 INDEPTH RESEARCH NOTE REA Group Ltd Neutral Price: A$72.97 Price Target: A$74.80 ASX: REA 12 February 2018 REA s first half FY18 (1H18) result was underpinned by strong growth in the Australian business

More information

Auckland International Airport

Auckland International Airport NEW ZEALAND AIA NZ Price (at 04:00, 27 Nov 2013 GMT) Neutral NZ$3.42 Valuation NZ$ 3.37 - DCF (WACC 8.0%, beta 0.9, ERP 7.0%, RFR 4.3%, TGR 3.0%) 12-month target NZ$ 3.37 12-month TSR % +2.6 Volatility

More information

RESEARCH NOTE GUD Holdings NEUTRAL

RESEARCH NOTE GUD Holdings NEUTRAL 1 RESEARCH NOTE GUD Holdings NEUTRAL Price: A$12.97 Price Target: A$12.61 ASX: GUD 2 February 2018 GUD Holdings (GUD) delivered 1H18 earnings of A30.2 cents per share, +15.7% over the previous corresponding

More information

INVESTOR PRESENTATION SG FLEET GROUP LIMITED - FY2016 RESULTS

INVESTOR PRESENTATION SG FLEET GROUP LIMITED - FY2016 RESULTS INVESTOR PRESENTATION SG FLEET GROUP LIMITED - FY2016 RESULTS 16 August 2016 Important Notice and Disclaimer IMPORTANT INFORMATION The information in this presentation is general in nature and does not

More information

Automotive Holdings Group

Automotive Holdings Group AUSTRALIA AHG AU Price (at 06:14, 11 Aug 2016 GMT) Outperform A$4.61 Valuation - EV/EBITA A$ 4.09-4.63 12-month target A$ 4.36 12-month TSR % -0.2 Volatility Index Low GICS sector Retailing Market cap

More information

Challenger Financial Services Group Limited

Challenger Financial Services Group Limited Challenger Financial Services Group Limited 2010 Interim Financial Results Financial Highlights For half year ended 31 Dec 2009 1H09 1H10 Assets Under Management* $22.9bn 12% Net income $272m 4% Expenses

More information

For personal use only

For personal use only AUSTRALIAN FINANCE GROUP LIMITED ABN 11 066 385 822 Appendix 4E Preliminary Final Report for the year ended 30 June 2015 Contents Page Results for announcement to market 2 Discussion and analysis of the

More information

Aust. General Insurance

Aust. General Insurance AUSTRALIA June 2016 3 mth rolling market results Personal Commercial Market Average Rate Growth -3. -3.6% -3.3% GWP Growth 1.8% -0.8% 0.9% Volume Growth 2.8% 0.8% 2.1% Est. Exposure Value Growth 2. 2.

More information

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation

Carsales.com. Motoring along nicely A$10.23 AUSTRALIA. Event. Impact. Earnings and target price revision. Price catalyst. Action and recommendation AUSTRALIA CRZ AU Price (at 9:48, 18 Feb 15 GMT) Outperform A$1.23 Valuation A$ 12.59 - DCF (WACC 8.1%, beta 1.2, ERP 5., RFR 3.8%, TGR 3.) 12-month target A$ 12.3 12-month TSR % +24.1 Volatility Index

More information

QANTM. Half Year Results Presentation. Leon Allen, Managing Director and CEO Martin Cleaver, Chief Financial Officer. Six months to 31 December 2017

QANTM. Half Year Results Presentation. Leon Allen, Managing Director and CEO Martin Cleaver, Chief Financial Officer. Six months to 31 December 2017 Half Year Results Presentation Six months to 31 December 2017 QANTM 22 FEBRUARY 2018 Leon Allen, Managing Director and CEO Martin Cleaver, Chief Financial Officer Disclaimer This presentation has been

More information